Think Locally, Act Globally

Slides:



Advertisements
Similar presentations
Synergies between the GAVI Alliance and health systems strengthening Dr. Craig Burgess, GAVI Secretariat 29 May 2008.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Global Measles and Rubella Strategic Plan
Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007.
Advance Market Commitments for Vaccines Carlo Monticelli International Financial Relations Ministero dell’Economia e delle Finanze.
Pre Tender Meeting UNICEF Supply Division, December 2008 Rob Matthews UNICEF Vaccine Procurement for Developing Countries.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
World Health Editors Network (WHEN) 66th World Health Assembly
Child Care Provider Parents Siblings GrandparentsHealthcare Worker.
Basic facts about the GAVI Alliance Speaker
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
1 Roots of the Second Child Survival Revolution Cesar Victora Federal University of Pelotas, Brazil Bellagio Child Survival Study Group Countdown to 2015.
Kristine Sheedy, PhD Associate Director for Communication Science National Center for Immunization and Respiratory Diseases The Importance of Effective.
Infrastructure Consortium Meeting June IFF for Immunziation Andrew Jones Senior Programme Officer, Innovative Financing.
Countdown to 2015: Tracking Progress in Child Survival. London, December Thinking Big: Going into Action for Child Survival Sustainable Financing.
Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.
Introduction of Hib in UIP Dr. Prashant P. Ghodam Moderator : Dr. Ranjan Solanki.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Keeping promises, Measuring results: The Global Strategy and Accountability for Women's and Children's Health Bernadette Daelmans Family, Women and Children's.
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
MEASLES AND RUBELLA INITIATIVE Presentation by : Sylvia Khamati. Health Advisor Kenya Red Cross Society “Story from the Field” 15 th September 2015 American.
2005 National Immunization Survey Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC National Press Club July 27, 2005 Department.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Thomas Clark, MD, MPH Centers for Disease Control and Prevention Immunization Program Managers Meeting November 16, 2010 Pertussis Epidemiology in the.
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
Pfizer’s Commitment to the Advance Market Commitment (AMC)
INNOVATIVE FINANCE: HELPING SAVE MORE LIVES Paolo Sison Director, Innovative Finance Tbilisi International Solidarity and Innovative Financing.
This vaccine webinar series is provided as a community service by Homefirst Natural Pharm Source
The National Vaccine Plan Update: Recent Activities and Next Steps Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
GAVI, IFFIm & Vaccine Bonds Overview International Finance ’14 Michelle Han 132SIS48.
Pneumococcal Vaccine Use Around the World: Successes and Challenges Adam L. Cohen, MD MPH Respiratory Diseases Branch, Division of Bacterial Diseases Centers.
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
BASIC FACTS ABOUT GAVI, THE VACCINE ALLIANCE Page: 1 #vaccineswork Gavi/2012/Doune Porter.
ADULT IMMUNIZATION An Unexploited Opportunity for Prevention William Schaffner, MD Professor of Preventive Medicine Department of Health Policy Professor.
The Great Exposé on Global Vaccination Strategies Kris Gaublomme, MD February 11, 2009.
Vaccine Development, Innovations and Investments Oslo Malaria Conference, “Getting To Zero” Jean Stéphenne, Chairman and President GlaxoSmithKline Biologicals.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Global Fund Work on HIV/SRH Linkages 09 March 2015 Olga Bornemisza New York, USA IAWG Meeting on HIV/SRH Linkages.
Gavi Judith Kallenberg, Head of Policy Duke Global Health Fellows 6 July 2016.
Impact of Rotavirus Vaccination in Latin America
PRODUCED IN PARTNERSHIP BY:
Session 4 Cross Cutting MR and RI Priorities Introduction
Global Overview of Measles
Some Perspectives on Vaccination of Adults
Innovative Financing Mechanisms
Overview of National Surveillance for Vaccine-Preventable Diseases
The International Finance Facility for Immunization (IFFIm)
World Health Organization
Emerging Gaps in Financing for New Vaccines
Are US Children In Compliance with Vaccination Recommendations?
Progress and Challenges with achieving Universal Immunization Coverage
Overview of vaccination programme in Malta
2010 Tennessee Immunization Requirements for School Entrance:
Take on Typhoid core slides
Update on the Nation’s Immunization
Immunizations for Young Children
Racial and ethnic disparities in childhood immunization rates have declined as overall coverage increased. Percentage of children ages 19 to 35 months.
Healthy People 2010 Focus Area 14
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Millennium Development Goals (MDGs)
Kenya Pediatric Association Conference,
National Immunization Conference
The Texas Child Care Immunization Assessment Survey
Presentation transcript:

Think Locally, Act Globally The 42nd National Immunization Conference, Atlanta, GA David Fleming, MD March 18, 2008

Impact of Vaccines in the 20th Century Disease 20th Century Annual Morbidity 2005 Total Percent Decrease Smallpox 48,164 100 Diphtheria 175,885 Pertussis 147,271 25,616 83 Tetanus 1,314 27 98 Polio (paralytic) 16,316 1* >99.9 Measles 503,282 66 Mumps 152,209 314 >99 Rubella 47,745 11 Congenital rubella 823 1 99.8 Haemophius influenzae (<5 yrs) 20,000 (est) 226 (serotype B or unknown) 99 *Imported vaccine-associated paralytic polio Sources: CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th Edition, January 2007. CDC. Impact of vaccines universally recommended for children – United States, 1900-1998. MMWR 1999;48(12):243-8. CDC. Notice to Readers: Final 2005 Reports of Notifiable Diseases. MMWR 2006;55(32):880-93.

A Ten Year Transformation in Global Immunization: 23/11/2018 12:4423/11/2018 12:44 23/11/2018 12:4423/11/2018 12:44 23/11/2018 12:44 Increased coverage for routine vaccines Substantial increase in coverage in developing countries, particularly sub-saharan Africa. Increased coverage for new and underused vaccines 15.6 million children immunised against hepatitis B 28.3 million children immunised against Hib 26.3 million children immunised against yellow fever Increased spending Spending on immunization in developing countries has risen from all sources. 4 4 HARWYN\Presentations\GROUP Presentation Oct 05 FINAL.ppt HARWYN\Presentations\GROUP Presentation Oct 05 FINAL.ppt HARWYN\Presentations\GROUP Presentation Oct 05 FINAL.ppt 4 4 4

Varicella vaccine uptake

+4 doses of diphtheria, tetanus toxiods, and pertussis vaccines; 3 doses of polio vaccine; 1 dose of measles-mumps-rubella vaccine; 3 doses of Haemophius influenzae type b vaccine; 3 doses of hepatitis vaccine

GAVI Alliance: a public-private partnership 10

Vaccine introduction strategy Alliance Introduction Design Agreement on policy objectives to guide introduction decisions Design of processes and methods for development of vaccine introduction strategy Alliance Vaccine Introduction Strategy Development Definition of Alliance’s vaccine introduction strategy Vaccines for introduction Activities for support (ADIP’S) Timeframe for introduction Thorough engagement with countries and other stakeholders WHO Vaccine Recommendations Thank WHO and SAGE for the work being done on this. Warmly welcome the expert guidance enabling well targeted activities- a core feature of the Alliance. Scale of new vaccines in pipeline requires consideration of how to prioritise investment. GAVI’s investment strategy will be presented to the Board by mid ’08. Definition of priority vaccines Recommendations for vaccine use Alliance process of analysis, evaluation and prioritization will start with this list 12

Funding innovations IFFIm: International Finance Facility for Immunisation: US$ 4 billion frontloaded from the capital markets AMC: Advance market commitment for pneumo vaccine: accelerating access 13

Health System Strengthening (HSS) US$800 million approved for the 2006-10 period Countries can use this flexible funding for individual priorities including: Recruiting and training health care workers Building/updating facilities Reporting & monitoring systems DECISION The GAVI Alliance Board: Feb 2008 Approved an increase in the GAVI Health Systems Strengthening window by US$ 300 million, allowing all countries to apply for one round, and three countries (Pakistan, Rwanda and Sierra Leone) with planning cycles ending in December 2009, to reapply for one additional round of funding. This decision is taken with the understanding that the above considerations will be addressed.   Reaching MDG 4 or 5 by 2015 will need significant investment in the Health Systems to actually deliver the health packages required to reduce childhood and maternal mortality and morbidity. The GAVI Alliance has launched an initial health strengthening investment of $500 million 2006 - 2010 that will assist countries to identify and overcome health system bottlenecks to delivering childhood health services, with a specific focus on immunization. This investment aims to integrate and harmonize as much as possible and will be driven by country feedback and needs. 14

Immunization Services Strengthening (ISS) Performance-based, data driven program. US$20 provided up front for each additional child pledged to be vaccinated. “No strings attached” to use of money. Local data with independent audits. Effective in increasing coverage rates across a range of baselines. DECISION The GAVI Alliance Board: Feb 2008 Approved an increase in the GAVI Health Systems Strengthening window by US$ 300 million, allowing all countries to apply for one round, and three countries (Pakistan, Rwanda and Sierra Leone) with planning cycles ending in December 2009, to reapply for one additional round of funding. This decision is taken with the understanding that the above considerations will be addressed.   Reaching MDG 4 or 5 by 2015 will need significant investment in the Health Systems to actually deliver the health packages required to reduce childhood and maternal mortality and morbidity. The GAVI Alliance has launched an initial health strengthening investment of $500 million 2006 - 2010 that will assist countries to identify and overcome health system bottlenecks to delivering childhood health services, with a specific focus on immunization. This investment aims to integrate and harmonize as much as possible and will be driven by country feedback and needs. 15

? Total doses administered in 2007 = 9750 Total doses for 100% coverage: 60,678 (based on 3-dose series, cohort of 11-12 yr females=20, 216) Proportion administered 16% 18

Panel Advises Flu Shots for Children Up to Age 18                                                                                                                                                                                      David Maxwell for The New York Times In 2006, Tommy Mericle received a flu shot at the Mahoning County District Board of Health in Ohio By LAWRENCE K. ALTMAN Published: February 28, 2008 All children ages 6 months to 18 years in this country should receive an influenza shot every year, a federal advisory panel said on Wednesday.

2006 National Coverage = 77% # States* Percent range 13 80-89% 32 70-79% 6 60-69% *includes DC http://www.cdc.gov/DataStatistics/2007/childimmunization/